Search

everythinglearnresearchcommunity

for

Search:↓

DPCP immunotherapy is effective for alopecia areata, and understanding influencing factors can improve treatment and satisfaction.

Atopic dermatitis in kids with alopecia areata can predict poor response to topical immunotherapy.

Topical immunotherapy can help with severe hair loss, but results vary and need personalized, long-term treatment.

Minoxidil helps treat eyebrow thinning, monilethrix, early hair loss, and shortens chemo-related hair loss.

Chronic stress in mice changes skin metabolism and gene expression, leading to hair loss.

Minoxidil foam helps hair growth by increasing good proteins and decreasing bad pathways in men with hair loss.

Tofacitinib may be safe for COVID-19 patients with alopecia without worsening symptoms, based on two cases.

Baricitinib works better in adolescents than adults for treating severe alopecia areata.

Ruxolitinib effectively regrows hair in most patients with severe hair loss.

Upadacitinib effectively treats skin conditions like eczema and psoriasis and is becoming more widely used and affordable.

Upadacitinib may effectively treat alopecia areata without side effects.

Cancer treatments often cause skin, nail, and hair problems.

iNOS contributes to hair loss in obese diabetic mice and blocking it may encourage hair growth.

Alopecia areata is an autoimmune condition causing hair loss, linked to genetic factors and immune system issues, with no cure yet.

Previous alopecia areata treatments do not affect the long-term effectiveness of ritlecitinib.

Topical drugs and near-infrared light therapy show potential for treating alopecia.

A woman with systemic sclerosis developed a unique scarring hair loss combining features of systemic sclerosis and frontal fibrosing alopecia.

Immunosuppressive and anti-TNF therapies in IBD patients can increase the risk of skin cancer and cause various skin issues.

Hormones during pregnancy and lactation keep skin stem cells inactive, preventing hair growth.

The current understanding of frontal fibrosing alopecia involves immune, genetic, hormonal factors, and possibly environmental triggers, but more research is needed for effective treatments.

Ruxolitinib treatment may cause eyelash growth.

Janus kinase inhibitors effectively treat alopecia areata but may cause relapses and have long-term safety concerns.

Ritlecitinib effectively improves hair growth in alopecia areata patients, regardless of hair loss pattern.

Baricitinib shows promise as a new treatment for certain skin conditions like alopecia areata.

Several new treatments for different types of hair loss show promise in improving patient quality of life.

Tildrakizumab may cause alopecia areata, but stopping it and using corticosteroids can regrow hair.

A man's severe skin reaction from cancer treatment improved with early diagnosis and proper medication.

Genetics can help tailor treatments for male pattern hair loss, improving outcomes like stabilization or modest regrowth.

Hair loss can be caused by cancer, treatments, or skin conditions, and trichoscopy helps diagnose it.

Alopecia areata is an autoimmune condition causing hair loss, influenced by genetics, stress, and diet, and may be prevented by a high soy oil diet.